Novo Nordisk a S: Form 20-F for the period ended Dec 31, 2025
Filed with the SEC on Feb 4, 2026 and accepted by EDGAR at Feb 4, 2026, 09:23 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | DKK 309.06bn | ifrs-full:Revenue |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | DKK 58.79bn | ifrs-full:CostOfSales |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | DKK 250.28bn | ifrs-full:GrossProfit |
| Operating income | 12 months2025-01-01 to 2025-12-31 | DKK 127.66bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2025-01-01 to 2025-12-31 | DKK 28.11bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2025-01-01 to 2025-12-31 | DKK 102.43bn | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | DKK 23.03 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | DKK 23.06 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | DKK 119.10bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | DKK 60.14bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2025-12-31 | DKK 26.46bn | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2025-12-31 | DKK 172.45bn | ifrs-full:CurrentAssets |
| Total assets | At period end2025-12-31 | DKK 542.90bn | ifrs-full:Assets |
| Current liabilities | At period end2025-12-31 | DKK 215.66bn | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2025-12-31 | DKK 348.86bn | ifrs-full:Liabilities |
| Shareholders' equity | At period end2025-12-31 | DKK 194.05bn | ifrs-full:Equity |
Source: SEC EDGAR, the filing index for accession 0000353278-26-000012. Last ingested by Listed: Nov 9, 2026, 17:51 ET. Listed shows no prices and gives no investment advice.